IN THIS ISSUE

Joseph Burns
Even today, studies show, only half of treatments are truly based on evidence. Here’s an organization looking to better that share, and it may behoove health plans to help.
Michael D. Dalzell
When a respected provider organization took a stand against the costly new cancer drug, it was both surprising and encouraging
Legislation & Regulation
John Carroll
While local governments ponder just what course to take, health plans prepare to grab as much market share as possible
Medication Management
Tom Reinke
Case management, prior authorization, and drug utilization control are required
Evidence Review

A summary of ECRI Institute’s Emerging Technology Evidence Report

Tomorrow's Medicine
Thomas Morrow, MD

Devices that selectively destroy the renal nerves that affect hypertension have gained international approval, and availability in the United States is not far off

Plan Watch
Frank Diamond

The insurer’s tracking effort helps physicians keep tabs on patients who may not be taking their drugs correctly

News & Commentary
News & Commentary